{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:40:11Z","timestamp":1789810811012,"version":"4.0.1"},"publisher-location":"Cham","reference-count":77,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319581927","type":"print"},{"value":"9783319581941","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/164_2016_130","type":"book-chapter","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T12:15:53Z","timestamp":1487852153000},"page":"301-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Clinical Development of Histamine H4 Receptor Antagonists"],"prefix":"10.1007","author":[{"given":"Robin L.","family":"Thurmond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Venable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Savall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Snook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Dunford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"key":"130_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/imm.12257","volume":"142","author":"SF Ahmad","year":"2014","unstructured":"Ahmad SF, Zoheir KMA, Abdel-Hamied HE, Alrashidi I, Attia SM, Bakheet SA, Ashour AE, Abd-Allah ARA (2014) Role of a histamine 4 receptor as an anti-inflammatory target in carrageenan-induced pleurisy in mice. Immunology 142:374\u2013383","journal-title":"Immunology"},{"key":"130_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.imbio.2015.01.008","volume":"220","author":"SF Ahmad","year":"2015","unstructured":"Ahmad SF, Ansari MA, Zoheir KMA, Bakheet SA, Korashy HM, Nadeem A, Ashour AE, Attia SM (2015) Regulation of TNF-\u03b1 and NF-\u03baB activation through the JAK\/STAT signaling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation. Immunobiology 220:889\u2013898","journal-title":"Immunobiology"},{"key":"130_CR3","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1021\/jm8005959","volume":"51","author":"RJ Altenbach","year":"2008","unstructured":"Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD (2008) Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem 51:6571\u20136580","journal-title":"J Med Chem"},{"key":"130_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146:657\u2013665","journal-title":"Ann Intern Med"},{"key":"130_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/327117a0","volume":"327","author":"JM Arrang","year":"1987","unstructured":"Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC (1987) Highly potent and selective ligands for histamine H3-receptors. Nature (London, U K) 327:117\u2013123","journal-title":"Nature (London, U K)"},{"key":"130_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bph.12263","volume":"170","author":"C Ballerini","year":"2013","unstructured":"Ballerini C, Aldinucci A, Luccarini I, Galante A, Manuelli C, Blandina P, Katebe M, Chazot PL, Masini E, Passani MB (2013) Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 170:67\u201377","journal-title":"Br J Pharmacol"},{"key":"130_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030285","volume":"7","author":"S Beermann","year":"2012","unstructured":"Beermann S, Glage S, Jonigk D, Seifert R, Neumann D (2012) Opposite effects of mepyramine on JNJ 7777120-induced amelioration of experimentally induced asthma in mice in sensitization and provocation. PLoS One 7:e30285","journal-title":"PLoS One"},{"key":"130_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/sj.bjp.0705754","volume":"142","author":"JK Bell","year":"2004","unstructured":"Bell JK, McQueen DS, Rees JL (2004) Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br J Pharmacol 142:374\u2013380","journal-title":"Br J Pharmacol"},{"key":"130_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/sj.bjp.0705530","volume":"140","author":"KF Buckland","year":"2003","unstructured":"Buckland KF, Williams TJ, Conroy DM (2003) Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br J Pharmacol 140:1117\u20131127","journal-title":"Br J Pharmacol"},{"key":"130_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejphar.2007.02.026","volume":"563","author":"G Coruzzi","year":"2007","unstructured":"Coruzzi G, Adami M, Guaita E, de Esch IJP, Leurs R (2007) Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 563:240\u2013244","journal-title":"Eur J Pharmacol"},{"key":"130_CR11","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1021\/jm800670r","volume":"51","author":"MD Cowart","year":"2008","unstructured":"Cowart MD, Altenbach RJ, Liu H, Hsieh GC, Drizin I, Milicic I, Miller TR, Witte DG, Wishart N, Fix-Stenzel SR, McPherson MJ, Adair RM, Wetter JM, Bettencourt BM, Marsh KC, Sullivan JP, Honore P, Esbenshade TA, Brioni JD (2008) Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 51:6547\u20136557","journal-title":"J Med Chem"},{"key":"130_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1465-9921-11-86","volume":"11","author":"JM Cowden","year":"2010","unstructured":"Cowden JM, Riley JP, Ma JY, Thurmond RL, Dunford PJ (2010a) Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir Res 11:86","journal-title":"Respir Res"},{"key":"130_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/jid.2009.358","volume":"130","author":"JM Cowden","year":"2010","unstructured":"Cowden JM, Zhang M, Dunford PJ, Thurmond RL (2010b) The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 130:1023\u20131033","journal-title":"J Invest Dermatol"},{"key":"130_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00011-013-0612-5","volume":"62","author":"JM Cowden","year":"2013","unstructured":"Cowden JM, Yu F, Challapalli M, Huang J-F, Kim S, Fung-Leung W-P, Ma JY, Riley JP, Zhang M, Dunford PJ, Thurmond RL (2013) Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo. Inflamm Res 62:599\u2013607","journal-title":"Inflamm Res"},{"key":"130_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/annrheumdis-2013-203832","volume":"73","author":"JM Cowden","year":"2014","unstructured":"Cowden JM, Yu F, Banie H, Farahani M, Ling P, Nguyen S, Riley JP, Zhang M, Zhu J, Dunford PJ, Thurmond RL (2014) The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis 73:600\u2013608","journal-title":"Ann Rheum Dis"},{"key":"130_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00541181","volume":"4","author":"AJ Crisp","year":"1984","unstructured":"Crisp AJ (1984) Studies of histamine in the rheumatoid joint. Rheumatol Int 4:125\u2013128","journal-title":"Rheumatol Int"},{"key":"130_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4049\/jimmunol.1101498","volume":"188","author":"R Rio del","year":"2012","unstructured":"del Rio R, Noubade R, Saligrama N, Wall EH, Krementsov DN, Poynter ME, Zachary JF, Thurmond RL, Teuscher C (2012) Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system. J Immunol 188:541\u2013547","journal-title":"J Immunol"},{"key":"130_CR18","doi-asserted-by":"publisher","first-page":"7062","DOI":"10.4049\/jimmunol.176.11.7062","volume":"176","author":"PJ Dunford","year":"2006","unstructured":"Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL (2006) The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 176:7062\u20137070","journal-title":"J Immunol"},{"key":"130_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaci.2006.08.034","volume":"119","author":"PJ Dunford","year":"2007","unstructured":"Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119:176\u2013183","journal-title":"J Allergy Clin Immunol"},{"key":"130_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/jm00243a009","volume":"18","author":"GJ Durant","year":"1975","unstructured":"Durant GJ, Ganellin CR, Parsons ME (1975) Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem 18:905\u2013909","journal-title":"J Med Chem"},{"key":"130_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ejmech.2012.06.016","volume":"54","author":"H Engelhardt","year":"2012","unstructured":"Engelhardt H, de Esch IJP, Kuhn D, Smits RA, Zuiderveld OP, Dobler J, Mayer M, Lips S, Arnhof H, Scharn D, Haaksma EEJ, Leurs R (2012) Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. Eur J Med Chem 54:660\u2013668","journal-title":"Eur J Med Chem"},{"key":"130_CR22","first-page":"13","volume":"13","author":"DB Frewin","year":"1986","unstructured":"Frewin DB, Cleland LG, Jonsson JR, Robertson PW (1986) Histamine levels in human synovial fluid. J Rheumatol 13:13\u201314","journal-title":"J Rheumatol"},{"key":"130_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/art.1780270803","volume":"27","author":"HP Godfrey","year":"1984","unstructured":"Godfrey HP, Ilardi C, Engber W, Graziano FM (1984) Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27:852\u2013856","journal-title":"Arthritis Rheum"},{"key":"130_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/art.1780400314","volume":"40","author":"I Gotis-Graham","year":"1997","unstructured":"Gotis-Graham I, McNeil PH (1997) Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum 40:479\u2013489","journal-title":"Arthritis Rheum"},{"key":"130_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/ard.57.11.664","volume":"57","author":"I Gotis-Graham","year":"1998","unstructured":"Gotis-Graham I, Smith MD, Parker A, McNeil HP (1998) Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 57:664\u2013671","journal-title":"Ann Rheum Dis"},{"key":"130_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M (2001) The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 10:11\u201318","journal-title":"Exp Dermatol"},{"key":"130_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1124\/jpet.102.046581","volume":"305","author":"CL Hofstra","year":"2003","unstructured":"Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung W-P (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305:1212\u20131221","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pbb.2009.12.004","volume":"95","author":"GC Hsieh","year":"2010","unstructured":"Hsieh GC, Chandran P, Salyers AK, Pai M, Zhu CZ, Wensink EJ, Witte DG, Miller TR, Mikusa JP, Baker SJ, Wetter JM, Marsh KC, Hancock AA, Cowart MD, Esbenshade TA, Brioni JD, Honore P (2010) H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 95:41\u201350","journal-title":"Pharmacol Biochem Behav"},{"key":"130_CR29","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1248\/bpb.28.2016","volume":"28","author":"Y Ikawa","year":"2005","unstructured":"Ikawa Y, Suzuki M, Shiono S, Ohki E, Moriya H, Negishi E, Ueno K (2005) Histamine H4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biol Pharm Bull 28:2016\u20132018","journal-title":"Biol Pharm Bull"},{"key":"130_CR30","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1021\/jm0341047","volume":"46","author":"JA Jablonowski","year":"2003","unstructured":"Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, Jiang W, Wilson SJ, Thurmond RL, Karlsson L, Edwards JP, Lovenberg TW, Carruthers NI (2003) The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 46:3957\u20133960","journal-title":"J Med Chem"},{"key":"130_CR31","first-page":"63","volume":"51","author":"SC Klein","year":"2010","unstructured":"Klein SC, Peterson ME (2010) Canine hypoadrenocorticism: part I. Can Vet J 51:63\u201369","journal-title":"Can Vet J"},{"key":"130_CR32","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.bmcl.2010.01.131","volume":"20","author":"JR Koenig","year":"2010","unstructured":"Koenig JR, Liu H, Drizin I, Witte DG, Carr TL, Manelli AM, Milicic I, Strakhova MI, Miller TR, Esbenshade TA, Brioni JD, Cowart M (2010) Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring. Bioorg Med Chem Lett 20:1900\u20131904","journal-title":"Bioorg Med Chem Lett"},{"key":"130_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.114.215749","volume":"350","author":"A Kollmeier","year":"2014","unstructured":"Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond R (2014) The H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther 350:181\u2013187","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1124\/jpet.105.087965","volume":"314","author":"HD Lim","year":"2005","unstructured":"Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: Identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310\u20131321","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.59.3.420","volume":"59","author":"C Liu","year":"2001","unstructured":"Liu C, Ma X-J, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420\u2013426","journal-title":"Mol Pharmacol"},{"key":"130_CR36","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.1021\/jm8007618","volume":"51","author":"H Liu","year":"2008","unstructured":"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LGR, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD (2008) cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem 51:7094\u20137098","journal-title":"J Med Chem"},{"key":"130_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.phrs.2016.07.037","volume":"111","author":"L Lucarini","year":"2016","unstructured":"Lucarini L, Pini A, Rosa AC, Lanzi C, Durante M, Chazot PL, Krief S, Schreeb A, Stark H, Masini E (2016) Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis. Pharmacol Res 111:740\u2013748","journal-title":"Pharmacol Res"},{"key":"130_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087296","volume":"9","author":"S Mahapatra","year":"2014","unstructured":"Mahapatra S, Albrecht M, Behrens B, Dittrich A-M, Jirmo A, Behrens G, Hartwig C, Neumann D, Bahre H, Raap U, Herrick C (2014) Delineating the role of histamine-1- and \u22124-receptors in a mouse model of th2-dependent antigen-specific skin inflammation. PLoS One 9:e87296","journal-title":"PLoS One"},{"key":"130_CR39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1600-0625.2012.01559.x","volume":"21","author":"A Matsushita","year":"2012","unstructured":"Matsushita A, Seike M, Okawa H, Kadawaki Y, Ohtsu H (2012) Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis. Exp Dermatol 21:714\u2013715","journal-title":"Exp Dermatol"},{"key":"130_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/1346-8138.12726","volume":"42","author":"Y Murata","year":"2015","unstructured":"Murata Y, Song M, Kikuchi H, Hisamichi K, Xu XL, Greenspan A, Kato M, Chiou C-F, Kato T, Guzzo C, Thurmond RL, Ohtsuki M, Furue M (2015) Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis. J Dermatol 42:129\u2013139","journal-title":"J Dermatol"},{"key":"130_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2009.02.035","volume":"608","author":"Y Nakano","year":"2009","unstructured":"Nakano Y, Takahashi Y, Ono R, Kurata Y, Kagawa Y, Kamei C (2009) Role of histamine H4 receptor in allergic conjunctivitis in mice. Eur J Pharmacol 608:71\u201375","journal-title":"Eur J Pharmacol"},{"key":"130_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(99)03111-6","volume":"354","author":"R Naumann","year":"1999","unstructured":"Naumann R, Felber W, Heilemann H, Reuster T (1999) Olanzapine-induced agranulocytosis. Lancet 354:566\u2013567","journal-title":"Lancet"},{"key":"130_CR43","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1398-9995.2012.02854.x","volume":"67","author":"Y Ohsawa","year":"2012","unstructured":"Ohsawa Y, Hirasawa N (2012) The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC\/Nga mice. Allergy 67:1014\u20131022","journal-title":"Allergy"},{"key":"130_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/pr.114.010249","volume":"67","author":"P Panula","year":"2015","unstructured":"Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WLS, Stark H, Thurmond RL, Haas HL (2015) International Union of Basic and Clinical Pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 67:601\u2013655","journal-title":"Pharmacol Rev"},{"key":"130_CR45","doi-asserted-by":"crossref","unstructured":"Petit-Bertron A-F, Machavoine F, Defresne MP, Gillard M, Chatelain P, Mistry P, Schneider E, Dy M (2009) H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells. PLoS One 4","DOI":"10.1371\/journal.pone.0006504"},{"key":"130_CR46","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2174\/13816128113199990553","volume":"20","author":"A Pini","year":"2014","unstructured":"Pini A, Somma T, Formicola G, Lucarini L, Bani D, Thurmond R, Masini E (2014) Effects of a selective histamine H4R antagonist on inflammation in a model of carrageenan-induced pleurisy in the rat. Curr Pharm Des 20:1338\u20131344","journal-title":"Curr Pharm Des"},{"key":"130_CR47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/jpet.114.215152","volume":"351","author":"AC Rosa","year":"2014","unstructured":"Rosa AC, Pini A, Lucarini L, Lanzi C, Veglia E, Thurmond RL, Stark H, Masini E (2014) Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment. J Pharmacol Exp Ther 351:308\u2013316","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-0625.2008.00762.x","volume":"18","author":"K Rossbach","year":"2009","unstructured":"Rossbach K, Wendorff S, Sander K, Stark H, Gutzmer R, Werfel T, Kietzmann M, Baeumer W (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18:57\u201363","journal-title":"Exp Dermatol"},{"key":"130_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2011.06.002","volume":"190","author":"K Rossbach","year":"2011","unstructured":"Rossbach K, Nassenstein C, Gschwandtner M, Schnell D, Sander K, Seifert R, Stark H, Kietzmann M, Baeumer W (2011) Histamine H1, H3 and H4 receptors are involved in pruritus. Neuroscience 190:89\u2013102","journal-title":"Neuroscience"},{"key":"130_CR50","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1016\/j.bmcl.2011.08.014","volume":"21","author":"BM Savall","year":"2011","unstructured":"Savall BM, Gomez L, Chavez F, Curtis M, Meduna SP, Kearney A, Dunford P, Cowden J, Thurmond RL, Grice C, Edwards JP (2011) Tricyclic aminopyrimidine histamine H4 receptor antagonists. Bioorg Med Chem Lett 21:6577\u20136581","journal-title":"Bioorg Med Chem Lett"},{"key":"130_CR51","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1021\/jm401727m","volume":"57","author":"BM Savall","year":"2014","unstructured":"Savall BM, Chavez F, Tays K, Dunford P, Cowden J, Hack MD, Wolin R, Thurmond RL, Edwards JP (2014) Discovery and SAR of 6-Alkyl-2,4-diaminopyrimidines as H4 receptor antagonists. J Med Chem 57:2429\u20132439","journal-title":"J Med Chem"},{"key":"130_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bcp.2015.09.006","volume":"98","author":"B Schirmer","year":"2015","unstructured":"Schirmer B, Rezniczek T, Seifert R, Neumann D (2015) Proinflammatory role of the histamine H4 receptor in dextrane sodium sulfate-induced acute colitis. Biochem Pharmacol 98:102\u2013109","journal-title":"Biochem Pharmacol"},{"key":"130_CR53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuropharm.2015.05.004","volume":"106","author":"EH Schneider","year":"2016","unstructured":"Schneider EH, Seifert R (2016) The histamine H4-receptor and the central and peripheral nervous system: a critical analysis of the literature. Neuropharmacology 106:116\u2013128","journal-title":"Neuropharmacology"},{"key":"130_CR54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1398-9995.2009.02240.x","volume":"65","author":"M Seike","year":"2010","unstructured":"Seike M, Furuya K, Omura M, Hamada-Watanabe K, Matsushita A, Ohtsu H (2010) Histamine H4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 65:319\u2013326","journal-title":"Allergy"},{"key":"130_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2011.11.027","volume":"675","author":"N Shin","year":"2012","unstructured":"Shin N, Covington M, Bian D, Zhuo J, Bowman K, Li Y, Soloviev M, Qian D-Q, Feldman P, Leffet L, He X, Wang KH, Krug K, Bell D, Czerniak P, Hu Z, Zhao H, Zhang J, Yeleswaram S, Yao W, Newton R, Scherle P (2012) INCB38579, a novel and potent histamine H4 receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions. Eur J Pharmacol 675:47\u201356","journal-title":"Eur J Pharmacol"},{"key":"130_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000125048","volume":"14","author":"FM Smith","year":"2007","unstructured":"Smith FM, Haskelberg H, Tracey DJ, Moalem-Taylor G (2007) Role of histamine H3 and H4 receptors in mechanical hyperalgesia following peripheral nerve injury. Neuroimmunomodulation 14:317\u2013325","journal-title":"Neuroimmunomodulation"},{"key":"130_CR57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bph.12264","volume":"170","author":"T Somma","year":"2013","unstructured":"Somma T, Cinci L, Formicola G, Pini A, Thurmond R, Ennis M, Bani D, Masini E (2013) A selective antagonist of histamine H4 receptors prevents antigen-induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-1. Br J Pharmacol 170:200\u2013213","journal-title":"Br J Pharmacol"},{"key":"130_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejphar.2011.05.037","volume":"667","author":"E Suwa","year":"2011","unstructured":"Suwa E, Yamaura K, Oda M, Namiki T, Ueno K (2011) Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol 667:383\u2013388","journal-title":"Eur J Pharmacol"},{"key":"130_CR59","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.intimp.2009.02.011","volume":"9","author":"Y Takahashi","year":"2009","unstructured":"Takahashi Y, Kagawa Y, Izawa K, Ono R, Akagi M, Kamei C (2009) Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol 9:734\u2013738","journal-title":"Int Immunopharmacol"},{"key":"130_CR60","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1124\/jpet.103.057489","volume":"307","author":"K Takeshita","year":"2003","unstructured":"Takeshita K, Sakai K, Bacon KB, Gantner F (2003) Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 307:1072\u20131078","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR61","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ajh.21433","volume":"84","author":"D Tesfa","year":"2009","unstructured":"Tesfa D, Keisu M, Palmblad J (2009) Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 84:428\u2013434","journal-title":"Am J Hematol"},{"key":"130_CR62","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/ard.54.11.896","volume":"54","author":"LC Tetlow","year":"1995","unstructured":"Tetlow LC, Woolley DE (1995) Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalization studies. Ann Rheum Dis 54:896\u2013903","journal-title":"Ann Rheum Dis"},{"key":"130_CR63","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/ard.55.8.548","volume":"55","author":"LC Tetlow","year":"1996","unstructured":"Tetlow LC, Woolley DE (1996) Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages. Ann Rheum Dis 55:548\u2013551","journal-title":"Ann Rheum Dis"},{"key":"130_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","volume":"387","author":"D Thaci","year":"2015","unstructured":"Thaci D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, Soong W, Worm M, Szepietowski JC, Sofen H, Kawashima M, Wu R, Weinstein SP, Graham NMH, Pirozzi G, Teper A, Sutherland ER, Mastey V, Stahl N, Yancopoulos GD, Ardeleanu M (2015) Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 387:40\u201352","journal-title":"Lancet"},{"key":"130_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2015.00065","volume":"6","author":"RL Thurmond","year":"2015","unstructured":"Thurmond RL (2015) The histamine H4 receptor: from orphan to the clinic. Front Pharmacol 6:1\u201311","journal-title":"Front Pharmacol"},{"key":"130_CR66","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1124\/jpet.103.061754","volume":"309","author":"RL Thurmond","year":"2004","unstructured":"Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung W-P, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309:404\u2013413","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1124\/jpet.113.211714","volume":"349","author":"RL Thurmond","year":"2014","unstructured":"Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL (2014) Clinical and preclinical characterization of the histamine H4 receptor antagonist JNJ-39758979. J Pharmacol Exp Ther 349:176\u2013184","journal-title":"J Pharmacol Exp Ther"},{"key":"130_CR68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-3-662-44605-8_15","volume":"226","author":"RL Thurmond","year":"2015","unstructured":"Thurmond RL, Kazerouni K, Chaplan SR, Greenspan AJ (2015) Antihistamines and itch. Handb Exp Pharmacol 226:257\u2013290","journal-title":"Handb Exp Pharmacol"},{"key":"130_CR70","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3899\/jrheum.160164","volume":"43","author":"RL Thurmond","year":"2016","unstructured":"Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS (2016) Toreforant, a histamine H4 receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate therapy: results of 2 phase II studies. J Rheumatol 43:1637\u20131642","journal-title":"J Rheumatol"},{"key":"130_CR69","unstructured":"Thurmond RL, Chen B, Dunford PJ, Eckert W, Karlsson L, La D, Ward P, Xu XL, Greenspan AJ (2017) Pharmacology and clinical activity of toreforant, a histamine H4 receptor antagonist. J Ann Pharmacol Pharm (in press.)"},{"key":"130_CR71","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejphar.2005.08.045","volume":"522","author":"C Varga","year":"2005","unstructured":"Varga C, Horvath K, Berko A, Thurmond RL, Dunford PJ, Whittle BJR (2005) Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur J Pharmacol 522:130\u2013138","journal-title":"Eur J Pharmacol"},{"key":"130_CR72","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1021\/jm0502081","volume":"48","author":"JD Venable","year":"2005","unstructured":"Venable JD, Cai H, Chai W, Dvorak CA, Grice CA, Jablonowski JA, Shah CR, Kwok AK, Ly KS, Pio B, Wei J, Desai PJ, Jiang W, Nguyen S, Ling P, Wilson SJ, Dunford PJ, Thurmond RL, Lovenberg TW, Karlsson L, Carruthers NI, Edwards JP (2005) Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: Potent human histamine H4 antagonists. J Med Chem 48:8289\u20138298","journal-title":"J Med Chem"},{"key":"130_CR73","doi-asserted-by":"crossref","unstructured":"Wang M, Han J, Domenico J, Shin YS, Jia Y, Gelfand EW (2016) Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function. Allergy 71:1561\u20131574","DOI":"10.1111\/all.12904"},{"key":"130_CR74","unstructured":"Werfel T, Lynch V, Asher A, Tsianakas A, Gupta B, Sarmiento R, Ploszczuk A, Kuna P, Majorek-Olechowska B, Cimoszko B, Nikkels A, Hofman T, Staubach P, Breuer K, Gawlik A, Buczylko K, Morren M-A, Layton G, Yeadon M, Whitlock L, Purkins L, Liu W, Osterloh I, Jimenez P (2016) A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389), a potent, oral histamine H4 receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults. In: EAACI 2016 meeting abstract"},{"key":"130_CR75","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1056\/NEJMcp042803","volume":"352","author":"HC Williams","year":"2005","unstructured":"Williams HC (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352:2314\u20132324","journal-title":"N Engl J Med"},{"key":"130_CR76","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2131\/jts.34.427","volume":"34","author":"K Yamaura","year":"2009","unstructured":"Yamaura K, Oda M, Suwa E, Suzuki M, Sato H, Ueno K (2009) Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 34:427\u2013431","journal-title":"J Toxicol Sci"},{"key":"130_CR77","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1517\/13543784.15.11.1443","volume":"15","author":"M Zhang","year":"2006","unstructured":"Zhang M, Venable JD, Thurmond RL (2006) The histamine H4 receptor in autoimmune disease. Expert Opin Investig Drugs 15:1443\u20131452","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Handbook of Experimental Pharmacology","Histamine and Histamine Receptors in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T15:53:15Z","timestamp":1558021995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2016_130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319581927","9783319581941"],"references-count":77,"URL":"https:\/\/doi.org\/10.1007\/164_2016_130","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"24 February 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}